Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

TUYA vs ZEPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TUYA Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

TUYA Overall Winner 6-Pillar Tally: TUYA 3 – 2 ZEPP (1 Tie) Matrix Metrics: TUYA 7 – 3 ZEPP

As of Nov 20, 2026, Tuya Inc. (TUYA) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TUYA carries a Unified Composite Score of 40.5/100 (SELL) at $1.46 (10.8x Forward P/E, 8.4% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin).

  • Composite vs. Pillar Nuance: While ZEPP currently prints a higher short-term Unified Composite Score (45.7/100 HOLD vs. TUYA 40.5/100 SELL), TUYA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (8.4% vs. -12.6% operating margin) and revenue trajectory (+16.0% vs. +6.9% YoY).
  • Technical & Structure Timing Caution: TUYA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TUYA vs ZEPP
TUYA NYSE Head-to-Head Winner
Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share
Services-Prepackaged Software
$1.46
-5.19% 1D
Market Cap $944.3M
TTM Revenue $1.12B
Forward P/E 10.8x
Beta / 30D Vol 0.90β · 34% Vol
Unified Composite Score
40.5 / 100 SELL
Tech 23.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 30
RSI-14: 30.0 · SMA20: $1.60 · SMA50: $1.67
ZEPP NYSE
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
Electronic Computers
$2.31
-8.33% 1D
Market Cap $37.0M
TTM Revenue $276M
Forward P/E 3.1x
Beta / 30D Vol 2.12β · 68% Vol
Unified Composite Score
45.7 / 100 HOLD
Tech 63.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -25.0%), weak momentum, RSI 35
RSI-14: 35.4 · SMA20: $2.40 · SMA50: $3.21

6-Pillar Scorecard Institutional Category Breakdown (TUYA 3 – 2 ZEPP)

Columns: Metric · TUYA · ZEPP
1. Valuation Multiples ZEPP
Forward P/E 10.8x 3.1x
Trailing P/E 14.0x 3.1x
PEG Ratio N/M N/M
EV / Revenue 0.8x 0.1x
2. Growth & Scale TUYA
Revenue Growth (YoY) +16.0% +6.9%
Earnings Growth (YoY) +50.0% -68.1%
TTM Revenue (USD) $1.12B $276M
Market Cap $944.3M $37.0M
3. Profitability & Quality TUYA
Gross Margin 47.2% 38.6%
Operating Margin 8.4% -12.6%
Net Profit Margin 20.2% -15.8%
Return on Equity (ROE) 6.7% -21.2%
4. Balance Sheet & Cash Flow TUYA
Cash Generation (TTM) $97M EBITDA -$30M EBITDA
Cash Flow Margin 8.7% EBITDA Mgn -11.0% EBITDA Mgn
Net Cash / Leverage $1.67 Book/Sh · 6.7% ROE $11.68 Book/Sh · -21.2% ROE
Dividend Yield 3.93% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 65.9% (100th %ile) 124.3% (94th %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ZEPP
OpEx & R&D Intensity 38.8% of Rev ($433M) 51.2% of Rev ($141M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Consumer Electronics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TUYA (7) vs ZEPP (3)
Institutional Metric TUYA ZEPP Criterion Row Edge
Market Capitalization
Scale
$944.3M $37.0M Larger Scale TUYA
Trailing P/E Ratio
Valuation
14.0x 3.1x Lower Multiple ZEPP
Forward P/E Ratio
Valuation
10.8x 3.1x Lower Multiple ZEPP
Revenue Growth (YoY)
Growth
+16.0% +6.9% Higher Growth TUYA
Operating Margin (TTM)
Profitability
8.4% -12.6% Higher Margin TUYA
Net Profit Margin
Profitability
20.2% -15.8% Higher Margin TUYA
Return on Equity (ROE)
Capital Efficiency
6.7% -21.2% Higher ROE TUYA
52-Week Range Position
Momentum
1% ($1–$3) 0% ($2–$33) Stronger Trend TUYA
Beta / 30D Volatility
Risk Regime
0.90β · 34% Vol 2.12β · 68% Vol Lower Realized Risk TUYA
Unified Institutional Score
Composite Signal
40.5 / 100 (SELL) 45.7 / 100 (HOLD) Higher Composite ZEPP
Trailing 12M Revenue (USD)
Operating Scale
$1.12B $276M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.2% 38.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.8x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$97M EBITDA ($1.67 Book/Sh · 6.7% ROE) -$30M EBITDA ($11.68 Book/Sh · -21.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TUYA +0.59 pp
TUYA: -12.57% · ZEPP: -13.16%
3M Horizon TUYA +36.66 pp
TUYA: -17.05% · ZEPP: -53.71%
6M Horizon TUYA +43.73 pp
TUYA: -29.47% · ZEPP: -73.2%
1Y Horizon TUYA +61.96 pp
TUYA: -28.43% · ZEPP: -90.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TUYA vs ZEPP. Trailing 12-month operating profitability (TUYA 8.4% vs ZEPP -12.6%) and valuation multiples (TUYA 10.8x vs ZEPP 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

TUYA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.12B
Gross Margin47.2%
Op. Margin8.4%
ROE / Fwd P/E6.7% · 10.8x
ZEPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$276M
Gross Margin38.6%
Op. Margin-12.6%
ROE / Fwd P/E-21.2% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TUYA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 65.9%
IV Percentile 100th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TUYA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ZEPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 124.3%
IV Percentile 94th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ZEPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TUYA Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $944.3M market capitalization and 8.4% operating margin.
OpEx & R&D Reinvestment 38.8% of Rev ($433M)
90D Engineering Disclosures 0 Published
ZEPP Moat Profile Cyclical / Execution-Driven Positioning
Consumer Electronics Operator
Competes within the Consumer Electronics value chain with $37.0M market capitalization and -12.6% operating margin.
OpEx & R&D Reinvestment 51.2% of Rev ($141M)
90D Engineering Disclosures 0 Published

Investor FAQ TUYA vs ZEPP Key Questions & Quantitative Answers

As of Nov 20, 2026, Tuya Inc. (TUYA) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TUYA carries a Unified Composite Score of 40.5/100 (SELL) at $1.46 (10.8x Forward P/E, 8.4% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin). Composite vs. Pillar Nuance: While ZEPP currently prints a higher short-term Unified Composite Score (45.7/100 HOLD vs. TUYA 40.5/100 SELL), TUYA captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (8.4% vs. -12.6% operating margin) and revenue trajectory (+16.0% vs. +6.9% YoY). Technical & Structure Timing Caution: TUYA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TUYA leads the Growth & Scale pillar: TUYA posts +16.0% YoY revenue growth and +50.0% YoY earnings growth on $1.12B TTM revenue (47.2% gross margin, 8.4% operating margin), compared with ZEPP at +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin). On trailing 12-month operating scale, TUYA generates $1.12B in USD-normalized revenue versus $276M for ZEPP. In operating R&D and SG&A reinvestment, TUYA deploys 38.8% of Rev ($433M) (0 90-day corporate R&D disclosures) versus 51.2% of Rev ($141M) (0 disclosures) for ZEPP.

ZEPP screens cheaper on headline valuation multiples. TUYA trades at 10.8x Forward P/E, 14.0x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (8.7% EBITDA margin), whereas ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TUYA (6.7% ROE) versus ZEPP (-21.2% ROE) capital efficiency.

In options market volatility and institutional positioning, TUYA carries 65.9% implied volatility (100th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.90β · 34% Vol realized risk). By comparison, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share (TUYA) Research Suite

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares (ZEPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.